Article
GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer
5 Jul 2019
Abstract excerpt
The prognosis of patients with progressive prostate cancers that are hormone refractory and/or have bone metastasis is poor. Multiple therapeutic targets to improve prostate cancer patient survival have been investigated, including orphan GPCRs. In our study, we identified G Protein-Coupled Receptor Class C Group 5 Member A (GPRC5A) as a candidate therapeutic molecule using integrative gene expression analyses of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
